ctDNA quantification improves estimation of outcomes in patients with high-grade osteosarcoma: a translational study from the OS2006 trial-Reference-Cited by-同舟云学术

ctDNA quantification improves estimation of outcomes in patients with high-grade osteosarcoma: a translational study from the OS2006 trial

Published:2023-12 Issue: Volume: Page:
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Audinot B.,Drubay D.^ORCID,Gaspar N.,Mohr A.,Cordero C.,Marec-Bérard P.,Lervat C.,Piperno-Neumann S.,Jimenez M.,Mansuy L.,Castex M.-P.,Revon-Riviere G.,Marie-Cardine A.,Berger C.,Piguet C.^ORCID,Massau K.,Job B.^ORCID,Moquin-Beaudry G.,Le Deley M.-C.,Tabone M.-D.,Berlanga P.,Brugières L.,Crompton B.D.,Marchais A.^ORCID,Abbou S.^ORCID

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference31 articles.

1. Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5;Trama;Lancet Oncol,2016

2. Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study;Gaspar;Eur J Cancer,2018

3. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial;Piperno-Neumann;Lancet Oncol,2016

4. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort;Smeland;Eur J Cancer,2019

5. Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects;Janeway;Lancet Oncol,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-informed deep sequencing of ctDNA detects minimal residual disease and predicts relapse in osteosarcoma;eClinicalMedicine;2024-07

2. Detection of pretreatment circulating tumor DNA as a biomarker of poor outcome in intermediate-risk rhabdomyosarcoma;Translational Pediatrics;2024-05